- Home
- SRRK vs CPRX Comparison
SRRK vs CPRX Comparison
Compare SRRK & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- CPRX
- Stock Information
- Founded
- SRRK 2012
- CPRX 2002
- Country
- SRRK United States
- CPRX United States
- Employees
- SRRK N/A
- CPRX N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SRRK Health Care
- CPRX Health Care
- Exchange
- SRRK Nasdaq
- CPRX Nasdaq
- Market Cap
- SRRK 3.2B
- CPRX 2.9B
- IPO Year
- SRRK 2018
- CPRX 2006
- Fundamental
- Price
- SRRK $37.44
- CPRX $21.81
- Analyst Decision
- SRRK Strong Buy
- CPRX Strong Buy
- Analyst Count
- SRRK 6
- CPRX 6
- Target Price
- SRRK $42.17
- CPRX $32.83
- AVG Volume (30 Days)
- SRRK 1.4M
- CPRX 1.4M
- Earning Date
- SRRK 08-07-2025
- CPRX 08-06-2025
- Dividend Yield
- SRRK N/A
- CPRX N/A
- EPS Growth
- SRRK N/A
- CPRX 178.13
- EPS
- SRRK N/A
- CPRX 1.57
- Revenue
- SRRK N/A
- CPRX $534,645,999.00
- Revenue This Year
- SRRK N/A
- CPRX $16.37
- Revenue Next Year
- SRRK $502.60
- CPRX $8.80
- P/E Ratio
- SRRK N/A
- CPRX $13.93
- Revenue Growth
- SRRK N/A
- CPRX 29.97
- 52 Week Low
- SRRK $6.76
- CPRX $15.34
- 52 Week High
- SRRK $46.98
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- SRRK 59.82
- CPRX 42.36
- Support Level
- SRRK $33.60
- CPRX $20.62
- Resistance Level
- SRRK $38.15
- CPRX $22.06
- Average True Range (ATR)
- SRRK 1.91
- CPRX 0.66
- MACD
- SRRK 0.21
- CPRX 0.03
- Stochastic Oscillator
- SRRK 89.12
- CPRX 56.67
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).